Literature DB >> 25500295

An unusual cause of acute kidney injury due to oxalate nephropathy in systemic scleroderma.

Heather M Mascio, Christie A Joya, Richard A Plasse, Thomas P Baker, Michael F Flessner, Robert Nee.   

Abstract

Oxalate nephropathy is an uncommon cause of acute kidney injury. Far rarer is its association with scleroderma, with only one other published case report in the literature. We report a case of a 75-year-old African-American female with a history of systemic scleroderma manifested by chronic pseudo-obstruction and small intestinal bacterial overgrowth (SIBO) treated with rifaximin, who presented with acute kidney injury with normal blood pressure. A renal biopsy demonstrated extensive acute tubular injury with numerous intratubular birefringent crystals, consistent with oxalate nephropathy. We hypothesize that her recent treatment with rifaximin for SIBO and decreased intestinal transit time in pseudo-obstruction may have significantly increased intestinal oxalate absorption, leading to acute kidney injury. Oxalate nephropathy should be considered in the differential diagnosis of acute kidney injury in scleroderma with normotension, and subsequent evaluation should be focused on bowel function to include alterations in gut flora due to antibiotic administration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25500295     DOI: 10.5414/CN108406

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

Review 1.  Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.

Authors:  Colin B Ligon; Laura K Hummers; Zsuzsanna H McMahan
Journal:  Semin Arthritis Rheum       Date:  2015-07-02       Impact factor: 5.532

2.  Acute oxalate nephropathy associated with orlistat.

Authors:  Youshay Humayun; Kenneth C Ball; Jack R Lewin; Anna A Lerant; Tibor Fülöp
Journal:  J Nephropathol       Date:  2016-03-29

3.  Secondary Oxalate Nephropathy: A Systematic Review.

Authors:  Nuttha Lumlertgul; Monchai Siribamrungwong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.